ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. H-2. ナノ生命科学研究所
  2. h-2 10.学術雑誌掲載論文
  3. 1. 査読済論文

Hepatocyte growth factor in physiology and infectious diseases

https://doi.org/10.24517/00027509
https://doi.org/10.24517/00027509
a0400746-f6d2-43df-b80c-6079b48feb51
名前 / ファイル ライセンス アクション
CA-PR-MATSUMOTO-K-97.pdf CA-PR-MATSUMOTO-K-97.pdf (1.6 MB)
license.icon
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2017-04-14
タイトル
タイトル Hepatocyte growth factor in physiology and infectious diseases
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
ID登録
ID登録 10.24517/00027509
ID登録タイプ JaLC
著者 Imamura, Ryu

× Imamura, Ryu

WEKO 256
e-Rad 10311680
金沢大学研究者情報 10311680
研究者番号 10311680

Imamura, Ryu

Search repository
松本, 邦夫

× 松本, 邦夫

WEKO 27
e-Rad 90201780
金沢大学研究者情報 90201780
研究者番号 90201780

ja ISNI

Search repository
著者別表示 今村, 龍

× 今村, 龍

今村, 龍

Search repository
松本, 邦夫

× 松本, 邦夫

ja ISNI

Search repository
提供者所属
内容記述タイプ Other
内容記述 ナノ生命科学研究所 / 金沢大学がん進展制御研究所
書誌情報 Cytokine

巻 98, p. 97-106, 発行日 2017-10-01
ISSN
収録物識別子タイプ ISSN
収録物識別子 1043-4666
NCID
収録物識別子タイプ NCID
収録物識別子 AA10794201
DOI
関連タイプ isVersionOf
識別子タイプ DOI
関連識別子 10.1016/j.cyto.2016.12.025
出版者
出版者 Academic Press / Elsevier
抄録
内容記述タイプ Abstract
内容記述 Hepatocyte growth factor (HGF) is a pleiotropic cytokine composed of an α-chain and a β-chain, and these chains contain four kringle domains and a serine protease-like structure, respectively. The receptor for HGF was identified as the c-met proto-oncogene product of transmembrane receptor tyrosine kinase. HGF-induced signaling through the receptor Met provokes dynamic biological responses that support morphogenesis, regeneration, and the survival of various cells and tissues, which includes hepatocytes, renal tubular cells, and neurons. Characterization of tissue-specific Met knockout mice has further indicated that the HGF-Met system modulates immune cell functions and also plays an inhibitory role in the progression of chronic inflammation and fibrosis. However, the biological actions that are driven by the HGF-Met pathway all play a role in the acquisition of the malignant characteristics in tumor cells, such as invasion, metastasis, and drug resistance in the tumor microenvironment. Even though oncogenic Met signaling remains the major research focus, the HGF-Met axis has also been implicated in infectious diseases. Many pathogens try to utilize host HGF-Met system to establish comfortable environment for infection. Their strategies are not only simply change the expression level of HGF or Met, but also actively hijack HGF-Met system and deregulating Met signaling using their pathogenic factors. Consequently, the monitoring of HGF and Met expression, along with real-time detection of Met activation, can be a beneficial biomarker of these infectious diseases. Preclinical studies designed to address the therapeutic significance of HGF have been performed on injury/disease models, including acute tissue injury, chronic fibrosis, and cardiovascular and neurodegenerative diseases. Likewise, manipulating the HGF-Met system with complete control will lead to a tailor made treatment for those infectious diseases. © 2016 Elsevier Ltd.
内容記述
内容記述タイプ Other
内容記述 Embargo Period 12 months
権利
権利情報 Copyright © Elsevier (CC-BY NC ND)
著者版フラグ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
関連URI
識別子タイプ URI
関連識別子 http://www.elsevier.com/locate/issn/10434666
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-27 10:13:29.313635
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3